Smart Cells have had great success in stem cell transplants and stem cell treatments, as well as winning awards in the healthcare sector including 2010 London Exporter of the Year.
Smart Cells are the only UK company to have had four stem cell transplants to date. These were for stem cell treatment of thallesaemia and cerebral palsey. We are currently involved with stem cell treatment clinical trials in the United States of America.
The Smart Cells laboratory houses the latest state of the art equipment and technology for the processing & storing of umbilical cord blood and umbilical cord tissue.
Smart Cells International adhere to the Human Tissue Act and is licensed by the Human Tissue Authority, HTA.
Umbilical cord tissue or cord cells are a rich source of Mesenchymal stem cells (MSC's), used in regenerative medicine for the repair of damaged cells of organs such as the Kidney, Liver or a damaged cartilage.
Smart Cells specialises in processing and storing of umbilical cord stem cells. These are stem cells from the umbilical cord blood and the umbilical cord tissue. Smart Cells International operates worldwide.
What makes Smart Cells different? Smart Cells was the first cord blood banking company in the UK to offer cord blood processing & storage. Smart Cells are the only company in the UK to have carried out stem cell treatment and stem cell transplants on behalf of their parents.
Shamshad Ahmed talks about the process of collecting and storing umbilical cord stem cells.
What can stem cells be used for? Stem cell treatment may be applied to blood related illnesses, certain types of blood cancers, non-hodgkins lymphoma, some genetic disorders, thallesaemia, neuroblastoma etc.
These are typically red blood cell disorders predominant in the Mediterranean Rim and the Middle East.
This section provides the latest news about stems cells as well as information and announcements made by Smart Cells. Use the ‘News type’ field to filter which type of news to filter.